• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Dishman Carbogen Amcis Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 67697.0
  • ISIN : INE385W01011
244.65 -10 (-3.78%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    242.40

  • Today’s High

    256.50

  • Open

    256.50

  • Perv Close

    254.25

  • 52W Low

    161.21

  • 52W High

    307.98

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    3,835.70

  • Div & Yield %

    0.00

  • Book Value(₹)

    257.07

  • Debt-Equity Ratio

    -3.78

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.40

  • Mar.Cap (₹Cr.)

    3,835.70

  • RONW (%)

    -2.68

  • ROCE (%)

    -0.03

Score Board

  • Equity (₹ in Cr.)

    31.36

  • BV (₹)

    257.10

  • Sales( ₹ in Cr.)

    399.84

  • NP (in Cr.)

    -9.87

  • NP Var(%)

    87.0

  • Div%

    0.0

  • CPS (₹)

    3.50

  • EPS (₹)

    -0.60

  • Traded Value (₹ in Lakhs)

    3,838.83

  • 52 Week High

    307.98

  • 52 Week Low

    161.21

  • Price BSE

    245.0

  • Price NSE

    245.00

  • Market Capital( in Cr.)

    3,838.83

  • P/C Ratio

    69.40

  • P/E Ratio

    -389.20

  • Price Vs.BV

    -0.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 327.35 402.55 306.61 200.32 580.74 549.47
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 327.35 402.55 306.61 200.32 580.74 549.47
Other Income 63.05 52.16 60.39 66.15 69.55 71.68
Stock Adjustments -8.27 -8.00 7.70 -22.54 -19.96 34.80
Total Income 382.13 446.71 374.70 243.93 630.33 655.95
EXPENDITURE :            
Raw Materials 107.70 163.35 107.11 75.04 180.15 197.38
Power and Fuel Cost 28.71 33.07 24.83 12.78 35.27 31.44
Employee Cost 91.54 86.13 79.04 58.23 88.87 80.27
Other Manufacturing Expenses 27.94 31.21 22.57 18.95 26.56 28.71
Selling and Administration Expenses 42.46 52.54 46.03 28.90 42.84 48.65
Miscellaneous Expenses 16.98 22.49 2.21 43.20 13.51 4.03
Employee Benefit Expenses 91.54 86.13 79.04 58.23 88.87 80.27
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 315.33 388.79 281.79 237.10 387.20 390.48
Operating Profit 66.80 57.92 92.91 6.83 243.13 265.47
Interest 68.19 57.92 37.23 34.17 47.02 47.43
Gross Profit -1.39 0.00 55.68 -27.34 196.11 218.04
Depreciation 101.61 96.20 140.07 141.35 140.65 136.31
Profit Before Tax -103.00 -96.20 -84.39 -168.69 55.46 81.73
Current Tax 11.06 0.00 0.00 17.97 9.30 17.01
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -37.65 -37.33 -52.84 46.15 7.64 8.71
Reported Net Profit -76.41 -58.87 -31.55 -232.81 38.52 56.01
Extraordinary Items -1.08 -2.79 -0.79 2.52 -4.06 0.16
Adjusted Net Profit -75.33 -56.08 -30.76 -235.33 42.58 55.85
Adjustment below Net Profit -0.07 0.33 0.10 -0.51 -0.27 0.34
P & L Balance brought forward -234.45 -175.91 -144.47 88.85 53.83 -2.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 3.23 0.00
P & L Balance carried down -310.93 -234.45 -175.92 -144.47 88.85 53.82
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 10.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.20
Earnings Per Share-Unit Curr -4.87 -3.75 -2.01 -14.85 2.46 3.47
Earnings Per Share(Adj)-Unit Curr -4.87 -3.75 -2.01 -14.85 2.46 3.47
Book Value 258.46 262.39 269.88 298.13 305.66 303.12
Book Value(Adj)-Unit Curr 258.46 262.39 269.88 298.13 305.66 303.12

Shareholding Pattern

  • Promoter Group

    59.32%

  • Public Share Holding

    40.68%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,000 0.00 5,000 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 93,007,442 59.32 93,007,442 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 15,569,501 9.93 15,569,501 62
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,684,917 1.07 1,684,917 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 312,500 0.20 312,500 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 17,566,918 11.20 17,566,918 71
2] Non Institution
Bodies Corporate 2,689,889 1.72 2,689,889 269
Clearing Members 373 0.00 373 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,389,888 0.89 1,389,888 955
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,180,290 0.75 1,180,290 1,235
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 17,824,974 11.37 17,824,974 26
Individuals holding nominal share capital up to Rs. 1 lakh 21,937,175 13.99 21,936,480 47,142
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,734 0.00 1,734 3
Others 32,786 0.02 32,786 2
Sub Total 46,208,735 29.47 46,208,040 49,667
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 156,783,095 100.00 156,782,400 49,744

Company Background

Dishman Carbogen Amcis LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Dishman Carbogen Amcis Ltd
  • BSE Code : 67697.0
  • ISIN : INE385W01011

  • Incorporation Year

    2007

  • Registered Office

    Dishman Corporate House
    Iscon-Bopal Road Ambli, Ahmedabad,
    Gujarat-380058

  • Telephone

    91-2717-400102/124

  • FAX

  • Chairman

    Janmejay R Vyas

  • Managing Director

    Arpit J Vyas

  • Company Secretary

    Shrima Dave

  • Auditor

    T R Chadha & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Dishman Carbogen Amcis Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Dishman Carbogen 244.85 390.40 327.35 -388.65 0.00
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10